Home › NDC Lookup › RxCUI directory › RxCUI 2107522

Insulin degludec 100 UNT/ML Injectable Solution [Tresiba] — RxCUI 2107522

Name: Insulin degludec 100 UNT/ML Injectable Solution [Tresiba] (RxCUI 2107522)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2107522 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2107522

Official nameInsulin degludec 100 UNT/ML Injectable Solution [Tresiba]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asTresiba 100 UNT/ML Injectable Solution

FDA products mapped3

Package NDCs mapped6

Reported Medicaid activity (SDUD)191,358 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Degludec (rDNA Origin) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Insulin degludec is a long-acting insulin used to help control blood sugar in people with type 1 or type 2 diabetes — including children as young as 1 year old. It gives your body...
What is insulin degludec (Tresiba) actually used for?
If you're an adult, you have flexibility — you can take it at any time of day that works for you, as long as at least 8 hours pass between doses if you ever need to adjust the timi...
When should I take it, and does it matter if I take it at different times each day?

📖 Read our full Insulin Degludec (rDNA Origin) Injection guide →

🕸️ Concept Web — How Insulin degludec 100 UNT/ML Injectable Solution... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Insulin degludec 100 UNT/ML Injectable Solution [Tresiba] RxCUI 2107522 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Insulin degludec 1670007 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tresiba 1670012 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Insulin degludec Injectable Solution 2107519 SCDF
- Insulin degludec Injectable Product 1670009 SCDG
- Insulin degludec Injectable Solution [Tresiba] 2107521 SBDF
- Tresiba Injectable Product 1670015 SBDG
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Insulin degludec 100 UNT/ML Injectable Solution 2107520 SCD
- Insulin degludec 100 UNT/ML 1670008 SCDC
- Insulin degludec 100 UNT/ML [Tresiba] 1670013 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Insulin degludec 100 UNT/ML Injectable Solution SCD · 2107520
Insulin degludec 100 UNT/ML SCDC · 1670008
Insulin degludec Injectable Solution SCDF · 2107519
Insulin degludec Injectable Product SCDG · 1670009

Brand-Name Concepts

Insulin degludec 100 UNT/ML [Tresiba] SBDC · 1670013
Insulin degludec Injectable Solution [Tresiba] SBDF · 2107521
Tresiba Injectable Product SBDG · 1670015
Tresiba BN · 1670012

📦 FDA Products & Package NDCs

3 products · 6 package NDCs

6 package NDCs map to RxCUI 2107522 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00169-2550-13	3 SYRINGE, PLASTIC in 1 CARTON (0169-2550-13) / 3 mL in 1 S...	Tresiba	Novo Nordisk	2015-09-25
00169-2550-97	1 SYRINGE, PLASTIC in 1 CARTON (0169-2550-97) / 3 mL in 1 S...	Tresiba	Novo Nordisk	2015-09-25
00169-2660-15	5 SYRINGE, PLASTIC in 1 CARTON (0169-2660-15) / 3 mL in 1 S...	Tresiba	Novo Nordisk	2015-09-25
00169-2660-97	1 SYRINGE, PLASTIC in 1 CARTON (0169-2660-97) / 3 mL in 1 S...	Tresiba	Novo Nordisk	2015-09-25
00169-2662-11	1 VIAL, GLASS in 1 CARTON (0169-2662-11) / 10 mL in 1 VIAL,...	Tresiba	Novo Nordisk	2019-02-05
00169-2662-90	1 VIAL, GLASS in 1 CARTON (0169-2662-90) / 10 mL in 1 VIAL,...	Tresiba	Novo Nordisk	2019-02-05

Observed labelers: Novo Nordisk (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.